Your browser doesn't support javascript.
loading
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
Klein, Nicola P; Lewis, Ned; Goddard, Kristin; Fireman, Bruce; Zerbo, Ousseny; Hanson, Kayla E; Donahue, James G; Kharbanda, Elyse O; Naleway, Allison; Nelson, Jennifer Clark; Xu, Stan; Yih, W Katherine; Glanz, Jason M; Williams, Joshua T B; Hambidge, Simon J; Lewin, Bruno J; Shimabukuro, Tom T; DeStefano, Frank; Weintraub, Eric S.
Afiliação
  • Klein NP; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
  • Lewis N; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
  • Goddard K; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
  • Fireman B; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
  • Zerbo O; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
  • Hanson KE; Marshfield Clinic Research Institute, Marshfield, Wisconsin.
  • Donahue JG; Marshfield Clinic Research Institute, Marshfield, Wisconsin.
  • Kharbanda EO; HealthPartners Institute, Minneapolis, Minnesota.
  • Naleway A; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  • Nelson JC; Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
  • Xu S; Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
  • Yih WK; Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
  • Glanz JM; Institute for Health Research, Kaiser Permanente Colorado, Denver.
  • Williams JTB; Department of Epidemiology, Colorado School of Public Health, Aurora.
  • Hambidge SJ; Ambulatory Care Services, Denver Health, Denver, Colorado.
  • Lewin BJ; University of Colorado School of Medicine, Aurora.
  • Shimabukuro TT; Ambulatory Care Services, Denver Health, Denver, Colorado.
  • DeStefano F; University of Colorado School of Medicine, Aurora.
  • Weintraub ES; Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
JAMA ; 326(14): 1390-1399, 2021 10 12.
Article em En | MEDLINE | ID: mdl-34477808
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2021 Tipo de documento: Article